Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2026RSC PharmaceuticsOpen Access

nor-MC3 and nor-KC2: Cationic Ionizable Lipids for the Delivery of Therapeutic Nucleic Acids

View Full Paper
Ask AI
Bookmark
Share

Authors

DAD.P. ArnoldPAPrasad AtmuriFSFariba Saadati

Discussion

Loading...

Member takes

Overview

Analogues nor-MC3 and nor-KC2 deliver nucleic acids effectively, suggesting potential therapeutic applications.

Key Points

  • This research aims to evaluate the efficacy of nor-MC3 and nor-KC2 as cationic lipids for delivering therapeutic nucleic acids.
  • Comparison of nor-MC3 and nor-KC2 with established cationic lipids.
  • Assessment of lipid efficacy in nucleic acid delivery.
  • Evaluation of structural modifications in lipophilic chains.
  • Nor-MC3 and nor-KC2 show comparable efficacy to existing cationic lipids.
  • Modified lipophilic chains do not adversely affect delivery performance.
  • Potential for use in therapeutic applications is highlighted.

Cite This Study

Arnold et al. (2026) studied this question.

synapsesocial.com/papers/69aa7066531e4c4a9ff5a25fhttps://doi.org/10.1039/d5pm00350d
View Full Paper
Ask AI
Bookmark
Share